482 related articles for article (PubMed ID: 26393791)
1. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
[TBL] [Abstract][Full Text] [Related]
2. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
3. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
Canalis E; Zanotti S; Schilling L; Eller T; Yu J
J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
[TBL] [Abstract][Full Text] [Related]
4. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
5. Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes.
Chia LY; Walsh NC; Martin TJ; Sims NA
Bone; 2015 Mar; 72():34-42. PubMed ID: 25460578
[TBL] [Abstract][Full Text] [Related]
6. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
Honma M; Ikebuchi Y; Kariya Y; Suzuki H
Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
[TBL] [Abstract][Full Text] [Related]
7. The Dmp1-SOST Transgene Interacts With and Downregulates the Dmp1-Cre Transgene and the Rosa(Notch) Allele.
Zanotti S; Canalis E
J Cell Biochem; 2016 May; 117(5):1222-32. PubMed ID: 26456319
[TBL] [Abstract][Full Text] [Related]
8. Matrix-embedded cells control osteoclast formation.
Xiong J; Onal M; Jilka RL; Weinstein RS; Manolagas SC; O'Brien CA
Nat Med; 2011 Sep; 17(10):1235-41. PubMed ID: 21909103
[TBL] [Abstract][Full Text] [Related]
9. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
[TBL] [Abstract][Full Text] [Related]
10. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
[TBL] [Abstract][Full Text] [Related]
11. The effect of osteocyte-derived RANKL on bone graft remodeling: An in vivo experimental study.
Feher B; Kampleitner C; Heimel P; Tangl S; Helms JA; Kuchler U; Gruber R
Clin Oral Implants Res; 2023 Dec; 34(12):1417-1427. PubMed ID: 37792417
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
14. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
Xiong J; Almeida M; O'Brien CA
Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
[TBL] [Abstract][Full Text] [Related]
15. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
[TBL] [Abstract][Full Text] [Related]
16. IL-6 exhibits both
McGregor NE; Murat M; Elango J; Poulton IJ; Walker EC; Crimeen-Irwin B; Ho PWM; Gooi JH; Martin TJ; Sims NA
J Biol Chem; 2019 May; 294(19):7850-7863. PubMed ID: 30923130
[TBL] [Abstract][Full Text] [Related]
17. Canonical Notch activation in osteocytes causes osteopetrosis.
Canalis E; Bridgewater D; Schilling L; Zanotti S
Am J Physiol Endocrinol Metab; 2016 Jan; 310(2):E171-82. PubMed ID: 26578715
[TBL] [Abstract][Full Text] [Related]
18. Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL.
Graves DT; Alshabab A; Albiero ML; Mattos M; Corrêa JD; Chen S; Yang Y
J Clin Periodontol; 2018 Mar; 45(3):285-292. PubMed ID: 29220094
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
[TBL] [Abstract][Full Text] [Related]
20. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.
Marahleh A; Kitaura H; Ohori F; Kishikawa A; Ogawa S; Shen WR; Qi J; Noguchi T; Nara Y; Mizoguchi I
Front Immunol; 2019; 10():2925. PubMed ID: 31921183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
